The team behind immuno-oncology success story Viralytics is back together and having another crack at developing a therapy harnessing a person’s own immune system to treat colorectal, ovarian and gastric cancers.
Led my Malcolm McColl, ImmVirX is investing in the development of another oncolytic viral immunotherapy, utilising RNA viruses to target specific receptor cells that are highly prevalent on these types of cancer cells.
Loading...
Yolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk. Connect with Yolanda on Twitter. Email Yolanda at yolanda.redrup@afr.com
